|
|
Article: Abundance of insomnia therapies in the pipeline.(Neuropsychiatric Medicine)
- Article from:
- Clinical Psychiatry News
- Article date:
- December 1, 2005
- Author:
CopyrightCOPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DENVER -- The pharmaceutical industry envisions the insomnia market as a field of dreams, judging by the sizable array of agents moving through the developmental pipeline.
And these aren't "me-too" drugs, either. They involve a wealth of new therapeutic targets and novel mechanisms of action.
"This is an exciting time in insomnia. There's a lot of movement in terms of how people are conceptualizing the problem clinically, there are new treatments coming up, and I think we're really going to have some better options for our patients in the near future," Daniel J. Buysse, M.D., said at a satellite symposium held with the annual meeting of the Associated ...